New patent for Xellia Pharms drug DAPTOMYCIN

October 13, 2023 Comments Off Posted in: Patent Added

Annual Drug Patent Expirations for DAPTOMYCIN Daptomycin is a drug marketed by Accord Hlthcare, Aspiro, Be Pharms, Dr Reddys, Eugia Pharma, Fresenius Kabi Usa, Hainan Poly Pharm, Hangzhou Zhongmei, Hengrui…

The post New patent for Xellia Pharms drug DAPTOMYCIN appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.